Mergers & Acquisitions
By The Online Investor Staff, updated Fri., Apr. 26, 4:51 AM
Slide #74. SciSparc Ltd. — AutoMax Motors Ltd.
Acquirer: |
SciSparc Ltd. (NASDAQ:SPRC) |
Acquiree: |
AutoMax Motors Ltd. |
Details: |
SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it signed a merger agreement (the "Agreement") with AutoMax Motors Ltd. ("AutoMax"), a leading vehicle importer company in Israel. |
SciSparc is a clinical-stage pharmaceutical company. Co.'s focus is creating and developing a portfolio of technologies and assets based on cannabinoid therapies. Co. is engaged in the following development programs based on delta9-tetrahydrocannabinol, and/or cannabidiol or other cannabinoid receptors agonists: SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea and patients with Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of Autism Spectrum Disorder and epilepsy.
Open the SPRC Page at The Online Investor »
Open the SPRC Page at The Online Investor (in a new window) »
|
April 26, 2024 4:51 AM Eastern
|